Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Drug symbols : Abbv save search
U.S. Food and Drug Administration (FDA) Grants Full Approval for ELAHERE® (mirvetuximab soravtansine-gynx) for Certain Ovarian Cancer Patients
Published: 2024-03-22 (Crawled : 19:00) - prnewswire.com
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
| Email alert
Add to watchlist
elahere drug approval food cancer grants
Global Irritable Bowel Disease (IBD) Market Research Report 2024: Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes Insights and Forecast 2019-2029
Published: 2024-03-13 (Crawled : 03:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: -0.07%
H: 0.09%
C: -0.7%
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: 0.27%
H: 0.5%
C: 0.11%
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: 0.59%
H: 0.01%
C: -1.45%
drug disease report research global market
Global Therapeutic Antibody Market Research Report 2024: Monoclonal, Bispecific, Drug Conjugates, Others Insights and Forecasts 2019-2029
Published: 2024-02-28 (Crawled : 03:00) - prnewswire.com
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: 0.67%
H: 0.0%
C: 0.0%
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: -0.36%
H: 0.1%
C: -0.6%
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: 0.6%
H: 0.02%
C: -1.03%
drug report antibody research global market
U.S. Food and Drug Administration (FDA) Grants Priority Review of Epcoritamab (EPKINLY®) for Difficult-to-Treat Relapsed or Refractory Follicular Lymphoma (FL)
Published: 2024-02-27 (Crawled : 13:30) - biospace.com/
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: 0.13%
H: 0.0%
C: 0.0%
epkinly drug review food grants
Global Advanced Drug Delivery Systems Market Report 2024: Review of Patents and Patent Applications Filed on Drug Delivery Release Mechanisms and Novel Applications
Published: 2024-02-15 (Crawled : 23:00) - prnewswire.com
TRUMF | $16.81 -17.59% 1.5K
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: -3.21%
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: 1.66%
H: 0.0%
C: -1.59%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.66%
H: 0.0%
C: -1.04%
TRUMY | $16.99 0.79% 50K
|
Manufacturing
|
| O: 0.27%
H: 0.0%
C: -2.6%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: 0.37%
H: 0.57%
C: 0.19%
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: -0.83%
H: 0.0%
C: 0.0%
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: 0.0%
drug patent report review global advanced market
Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published: 2024-01-30 (Crawled : 18:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 5.68%
H: 0.77%
C: 0.77%
AZNCF | $135.305 -4.19% 1.1K
|
Health Technology
|
| O: 3.41%
H: 0.0%
C: -2.45%
VTRS | $11.095 -0.22% -0.23% 6.1M
|
Health Technology
|
| O: -0.08%
H: 3.47%
C: -0.25%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: -2.04%
H: 0.19%
C: -1.97%
GSK | $39.6 -0.88% 0.0% 2.8M
|
Health Technology
|
| O: 4.04%
H: 1.57%
C: -3.02%
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: 0.5%
H: 0.07%
C: -0.81%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 1.75%
H: 0.0%
C: 0.0%
PBYI | $5.18 1.57% 1.54% 250K
|
Health Technology
|
| O: -0.1%
H: 2.31%
C: -1.26%
AZN | $68.53 0.39% 0.39% 3.7M
|
Health Technology
|
| O: 0.82%
H: 0.12%
C: -1.64%
AMGN | $264.07 -0.59% -0.59% 2.2M
|
Health Technology
|
| O: 0.44%
H: 0.2%
C: -0.55%
drug breast expected cancer pipeline therapeutics growth market
Implantable Drug Delivery Devices Global Market to Exhibit Growth at a Considerable CAGR of ~6% by 2028, Assesses DelveInsight
Published: 2024-01-23 (Crawled : 23:00) - prnewswire.com
TRUMF | $16.81 -17.59% 1.5K
|
Health Technology
|
| O: -4.99%
H: 0.0%
C: -0.06%
TRUMY | $16.99 0.79% 50K
|
Manufacturing
|
| O: -1.36%
H: 0.0%
C: -0.82%
WST | $377.36 -0.56% 0.0% 360K
|
Health Technology
|
| O: 0.67%
H: 0.46%
C: -1.49%
TFX | $208.3 -0.86% 0.0% 170K
|
Health Technology
|
| O: 0.18%
H: 0.52%
C: -2.57%
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: 0.61%
H: 1.52%
C: 0.03%
BMY | $47.84 -0.87% -0.02% 12M
|
Health Technology
|
| O: 0.16%
H: 0.84%
C: 0.08%
BSX | $67.96 -0.24% 1.53% 6.2M
|
Health Technology
|
| O: -0.18%
H: 0.5%
C: -0.98%
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: 1.44%
H: 0.0%
C: 0.0%
PODD | $166.245 -3.74% -3.89% 680K
|
Health Technology
|
| O: 0.07%
H: 1.08%
C: -1.59%
drug global growth market
Hospital Infection Therapeutics Market is to grow by USD 3.10 billion, Special drug designations to boost growth - Technavio
Published: 2024-01-23 (Crawled : 09:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -2.34%
H: 0.43%
C: 0.43%
AZNCF | $135.305 -4.19% 1.1K
|
Health Technology
|
| O: -2.16%
H: 1.17%
C: 1.17%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.46%
H: 0.0%
C: 0.0%
VTRS | $11.095 -0.22% -0.23% 6.1M
|
Health Technology
|
| O: 0.17%
H: 1.33%
C: 0.94%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: -0.96%
H: 0.3%
C: 0.28%
GSK | $39.6 -0.88% 0.0% 2.8M
|
Health Technology
|
| O: -0.76%
H: 0.38%
C: 0.13%
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: 0.37%
H: 0.0%
C: 0.0%
ABT | News | $105.9 -3.03% 0.07% 12M
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -2.05%
H: 0.0%
C: 0.0%
AZN | $68.53 0.39% 0.39% 3.7M
|
Health Technology
|
| O: -1.27%
H: 0.8%
C: 0.69%
drug hospital infection therapeutics growth market
Biological Drug API Manufacturing Services Market Report 2023-2033 - Single Use Technology will Become Essential Over the Next Decade
Published: 2023-12-28 (Crawled : 18:00) - prnewswire.com
TMO | News | $547.25 -1.32% -0.02% 1.6M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
CTLT | $55.96 0.32% 0.0% 1.9M
|
Health Technology
|
| O: -0.26%
H: 1.19%
C: 0.35%
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: 0.75%
H: 0.24%
C: -0.32%
drug services report technology market
AbbVie Announces U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) Updates for Epcoritamab (EPKINLY®/TEPKINLY®) for the Treatment of Relapsed/Refractory Follicular Lymphoma
Published: 2023-11-27 (Crawled : 12:00) - prnewswire.com
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
epkinly drug abbvie food treatment
Kadcyla Leads the Global Antibody Drug Conjugates Market with Extensive Use in Breast Cancer Treatment
Published: 2023-11-01 (Crawled : 18:00) - prnewswire.com
ALPMY | News | $9.34 -1.11% 690K
|
Manufacturing
|
| O: -1.46%
H: 3.67%
C: 3.26%
ZYME | $8.86 -0.78% -0.79% 370K
|
Health Technology
|
| O: 1.14%
H: 0.42%
C: -0.7%
TAK | $13.15 -0.61% 0.0% 1.6M
|
Health Technology
|
| O: 1.03%
H: 0.73%
C: 0.58%
ADCT | $4.96 11.71% 1.41% 1.2M
|
Health Technology
|
| O: -0.16%
H: 6.42%
C: 4.49%
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
STRO M | $3.78 -4.06% -4.23% 720K
|
Health Technology
|
| O: 0.39%
H: 3.86%
C: 3.86%
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 5.09%
H: 5.48%
C: -1.27%
GILD | $66.94 -0.55% -0.55% 5.3M
|
Health Technology
|
| O: -0.47%
H: 1.88%
C: 1.78%
EXEL | $22.875 0.24% 0.24% 2.8M
|
Health Technology
|
| O: -2.62%
H: 1.17%
C: -1.66%
drug antibody breast cancer treatment global market
EPKINLY™ (epcoritamab-bysp) Approved by U.S. Food and Drug Administration as the First and Only Bispecific Antibody to Treat Adults with Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)
Published: 2023-05-19 (Crawled : 16:00) - globenewswire.com
GNMSF | $285.11 3.83% 420
|
Health Technology
|
| O: 0.61%
H: 1.26%
C: 1.24%
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: 0.29%
H: 1.35%
C: 0.87%
GMAB | $28.51 -3.13% -3.23% 360K
|
Health Technology
|
| O: 0.54%
H: 2.0%
C: 1.81%
drug antibody approved food
Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions to Meet Increase in Investigational Drug Demand for Ongoing and Planned Clinical Trials
Published: 2023-05-02 (Crawled : 11:00) - globenewswire.com
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: -0.1%
H: 0.96%
C: -1.26%
PSTV | $1.74 -0.57% -0.57% 28K
|
Health Technology
|
| O: 2.01%
H: 0.0%
C: -9.09%
pharma drug ongoing trials solutions collaboration therapeutics plus
Ulcerative Colitis Drug Global Market Report 2022: Increasing Prevalence of Ulcerative Colitis and Inflammatory Bowel Diseases Bolsters Sector
Published: 2023-04-07 (Crawled : 11:00) - prnewswire.com
TAK | $13.15 -0.61% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
| Email alert
Add to watchlist
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
BHC | $8.66 -0.92% 0.0% 2.2M
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
| Email alert
Add to watchlist
BMY | $47.84 -0.87% -0.02% 12M
|
Health Technology
| Email alert
Add to watchlist
drug report global market
AbbVie Provides Regulatory Update on ABBV-951 (Foscarbidopa/Foslevodopa) New Drug Application
Published: 2023-03-22 (Crawled : 13:00) - prnewswire.com
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: -0.7%
H: 0.77%
C: -1.29%
abbv-951 drug abbvie update application
China Anti-Rheumatic Drug Markets Report 2022-2027 Featuring Pfizer, F. Hoffmann-La Roche, UCB S.A., Eli Lilly and Company, & AbbVie Inc.
Published: 2023-01-24 (Crawled : 12:00) - prnewswire.com
UCBJY | $63.31 -4.38% 9.4K
|
Manufacturing
|
| O: -1.31%
H: 0.39%
C: 0.17%
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: 12.34%
H: 0.0%
C: -9.9%
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: -0.32%
H: 0.53%
C: -0.26%
drug abbvie report china
Insights on the Allergic Conjunctivitis Global Market to 2031 - by Drug Class, Disease Type, Distribution Channel and Region
Published: 2023-01-05 (Crawled : 20:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: -1.84%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: 0.35%
H: 1.43%
C: 1.28%
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: 0.74%
H: 0.44%
C: 0.07%
BHC | $8.66 -0.92% 0.0% 2.2M
|
Health Technology
|
| O: 0.84%
H: 4.71%
C: 3.46%
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: 0.83%
H: 1.98%
C: 1.04%
drug global disease distribution market
AbbVie Submits Supplemental New Drug Application to U.S. FDA to Support New Indication of LINZESS® (linaclotide) for Functional Constipation in Children and Adolescents 6 to 17 Years of Age
Published: 2022-12-16 (Crawled : 13:00) - prnewswire.com
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: -0.64%
H: 0.78%
C: -0.97%
linzess fda drug children application
Pharmaceutical Drug Delivery Global Market Report 2022: Adoption of Nano-Based Drug Delivery Systems Presents Opportunities
Published: 2022-10-11 (Crawled : 20:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.93%
H: 0.0%
C: -0.17%
AZNCF | $135.305 -4.19% 1.1K
|
Health Technology
|
| O: -0.15%
H: 0.61%
C: 0.09%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: -0.07%
H: 0.48%
C: -0.66%
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: 1.29%
H: 0.0%
C: 0.0%
GSK | $39.6 -0.88% 0.0% 2.8M
|
Health Technology
|
| O: 0.0%
H: 0.67%
C: -0.2%
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: -0.07%
H: 1.92%
C: -0.86%
BSX | $67.96 -0.24% 1.53% 6.2M
|
Health Technology
|
| O: 0.38%
H: 0.35%
C: -0.28%
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: 0.09%
H: 1.0%
C: -1.17%
MMM | $90.96 -0.1% 0.0% 3.4M
|
Producer Manufacturing
|
| O: -0.25%
H: 1.04%
C: 0.35%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.76%
H: 0.0%
C: 0.0%
AZN | $68.53 0.39% 0.39% 3.7M
|
Health Technology
|
| O: -0.67%
H: 0.95%
C: 0.25%
AMGN | $264.07 -0.59% -0.59% 2.2M
|
Health Technology
|
| O: -0.44%
H: 1.79%
C: 0.85%
drug global report market
Disease-Modifying Antirheumatic Drug (DMARD) Market to Surpass US$ 27,167.8 Million by 2030 - Coherent Market Insights
Published: 2022-09-06 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -3.02%
H: 0.0%
C: 0.0%
UCBJY | $63.31 -4.38% 9.4K
|
Manufacturing
|
| O: 0.73%
H: 2.28%
C: 1.72%
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: -0.65%
H: 0.93%
C: 0.71%
BMY | $47.84 -0.87% -0.02% 12M
|
Health Technology
|
| O: 0.03%
H: 1.18%
C: 0.13%
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: -0.03%
H: 1.08%
C: 0.84%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.49%
H: 0.0%
C: 0.0%
GILD | $66.94 -0.55% -0.55% 5.3M
|
Health Technology
|
| O: 0.44%
H: 2.03%
C: 1.76%
CPIX | $1.66 6.41% 6.02% 7.4K
|
Health Technology
|
| O: -4.52%
H: 7.12%
C: 5.69%
AMGN | $264.07 -0.59% -0.59% 2.2M
|
Health Technology
|
| O: 0.24%
H: 1.04%
C: 0.82%
drug market
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.